Hims & Hers Health (HIMS) Intangibles (2020 - 2026)
Hims & Hers Health (HIMS) posted Intangibles of $261.0 million for Q1 2026, up 33.1% sequentially from $196.1 million in Q4 2025, and up 501.03% YoY from $43.4 million in Q1 2025.
Hims & Hers Health (HIMS) Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Intangibles for 7 years, with the latest figure at $261.0 million in Q1 2026.
- Quarterly Intangibles rose 501.03% year-over-year to $261.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $261.0 million (up 501.03% YoY) and the FY2025 annual result came in at $196.1 million, up 351.78% from the prior year.
- Intangibles rose to $261.0 million in Q1 2026 per HIMS's latest filing, from $196.1 million in the prior quarter.
- Over five years, Intangibles peaked at $261.0 million in Q1 2026 and troughed at $17.1 million in Q2 2024.
- A 5-year average of $60.6 million and a median of $23.8 million in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2026: Intangibles retreated 17.98% in 2022, then surged 501.03% in 2026.
- Over 5 years, Intangibles stood at $21.8 million in 2022, then declined by 14.96% to $18.6 million in 2023, then surged by 133.71% to $43.4 million in 2024, then soared by 351.78% to $196.1 million in 2025, then surged by 33.1% to $261.0 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $261.0 million, $196.1 million, and $194.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Hims & Hers Health | 7.81 Bn | 6.97 Bn | 480.80 Mn | 422.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 422.81 Mn |
| Mar 31, 2026 | 261.03 Mn |
| Dec 31, 2025 | 196.12 Mn |
| Sep 30, 2025 | 194.93 Mn |
| Jun 30, 2025 | 40.66 Mn |
| Mar 31, 2025 | 43.43 Mn |
| Dec 31, 2024 | 43.41 Mn |
| Sep 30, 2024 | 44.82 Mn |
| Jun 30, 2024 | 17.13 Mn |
| Mar 31, 2024 | 17.86 Mn |
| Dec 31, 2023 | 18.57 Mn |
| Sep 30, 2023 | 19.30 Mn |
| Jun 30, 2023 | 19.96 Mn |
| Mar 31, 2023 | 20.91 Mn |
| Dec 31, 2022 | 21.84 Mn |
| Sep 30, 2022 | 22.09 Mn |
| Jun 30, 2022 | 23.81 Mn |
| Mar 31, 2022 | 24.85 Mn |
| Dec 31, 2021 | 25.89 Mn |
| Sep 30, 2021 | 26.93 Mn |